KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 111 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $4,224,000 | -76.3% | 836,515 | -83.5% | 0.00% | -77.8% |
| Q3 2015 | $17,821,000 | -72.8% | 5,062,743 | -23.0% | 0.01% | -70.0% |
| Q2 2015 | $65,618,000 | -23.4% | 6,574,952 | -2.3% | 0.03% | -23.1% |
| Q1 2015 | $85,655,000 | +13.3% | 6,728,594 | +25.9% | 0.04% | +14.7% |
| Q4 2014 | $75,625,000 | +12.0% | 5,344,500 | +8.9% | 0.03% | +9.7% |
| Q3 2014 | $67,503,000 | +48.9% | 4,909,289 | +66.6% | 0.03% | +55.0% |
| Q2 2014 | $45,323,000 | -12.6% | 2,946,900 | -3.1% | 0.02% | -16.7% |
| Q1 2014 | $51,842,000 | +67.8% | 3,042,400 | +27.5% | 0.02% | +60.0% |
| Q4 2013 | $30,890,000 | +10.4% | 2,385,300 | -13.9% | 0.02% | 0.0% |
| Q3 2013 | $27,976,000 | +66.7% | 2,769,900 | +23.3% | 0.02% | +50.0% |
| Q2 2013 | $16,787,000 | – | 2,247,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 18,300,000 | $258,945,000 | 5.09% |
| EcoR1 Capital, LLC | 589,000 | $8,334,000 | 4.22% |
| Camber Capital Management LP | 3,000,000 | $42,450,000 | 2.82% |
| Cormorant Asset Management, LP | 1,000,000 | $14,150,000 | 2.18% |
| SECTORAL ASSET MANAGEMENT INC | 3,257,358 | $46,092,000 | 2.07% |
| Knoll Capital Management, LLC | 200,000 | $2,830,000 | 1.11% |
| OAK RIDGE INVESTMENTS LLC | 3,247,990 | $45,959,000 | 1.10% |
| NORTHPOINTE CAPITAL LLC | 514,445 | $7,279,000 | 0.87% |
| Apex Capital Management | 1,843,754 | $26,089,000 | 0.70% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,183,484 | $16,746,000 | 0.60% |